253 related articles for article (PubMed ID: 32379303)
21. Barriers to mesalamine adherence in patients with inflammatory bowel disease: a qualitative analysis.
Devlen J; Beusterien K; Yen L; Ahmed A; Cheifetz AS; Moss AC
J Manag Care Spec Pharm; 2014 Mar; 20(3):309-14. PubMed ID: 24564811
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients' Perspective.
Grunert PC; Reuken PA; Stallhofer J; Teich N; Stallmach A
J Crohns Colitis; 2020 Dec; 14(12):1702-1708. PubMed ID: 32564068
[TBL] [Abstract][Full Text] [Related]
23. Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease.
Selinger CP; Eaden J; Jones DB; Katelaris P; Chapman G; McDonald C; Smith P; Lal S; Leong RW; McLaughlin J; Robinson A
Inflamm Bowel Dis; 2013 Sep; 19(10):2199-206. PubMed ID: 23899547
[TBL] [Abstract][Full Text] [Related]
24. Medication beliefs among patients with inflammatory bowel disease who report low quality of life: a qualitative study.
Hall NJ; Rubin GP; Hungin AP; Dougall A
BMC Gastroenterol; 2007 Jun; 7():20. PubMed ID: 17559670
[TBL] [Abstract][Full Text] [Related]
25. Medication beliefs and structural barriers to treatment adherence among people living with HIV infection.
Kalichman S; Kalichman MO; Cherry C
Psychol Health; 2016; 31(4):383-95. PubMed ID: 26534788
[TBL] [Abstract][Full Text] [Related]
26. Reproductive Health and Medication Concerns for Patients With Inflammatory Bowel Disease: Thematic and Quantitative Analysis Using Social Listening.
Keller MS; Mosadeghi S; Cohen ER; Kwan J; Spiegel BMR
J Med Internet Res; 2018 Jun; 20(6):e206. PubMed ID: 29891471
[TBL] [Abstract][Full Text] [Related]
27. The 'Necessity-Concerns Framework' as a means of understanding non-adherence by applying polynomial regression in three chronic conditions.
West LM; Borg Theuma R; Cordina M
Chronic Illn; 2020 Dec; 16(4):253-265. PubMed ID: 30235934
[TBL] [Abstract][Full Text] [Related]
28. The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort study.
Massey EK; Tielen M; Laging M; Beck DK; Khemai R; van Gelder T; Weimar W
J Psychosom Res; 2013 Sep; 75(3):229-34. PubMed ID: 23972411
[TBL] [Abstract][Full Text] [Related]
29. Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz.
Cooper V; Moyle GJ; Fisher M; Reilly G; Ewan J; Liu HC; Horne R;
AIDS Care; 2011 Jun; 23(6):705-13. PubMed ID: 21476152
[TBL] [Abstract][Full Text] [Related]
30. Exploring the Multidimensional Relationship Between Medication Beliefs and Adherence to Medications Among Older Adults Living With Multimorbidity Using Polynomial Regression: An Observational Cohort Study.
Foley L; Doherty AS; Wallace E; Boland F; Hynes L; Murphy AW; Molloy GJ
Ann Behav Med; 2023 Jun; 57(7):561-570. PubMed ID: 37000216
[TBL] [Abstract][Full Text] [Related]
31. Using the extended self-regulatory model to characterise diabetes medication adherence: a cross-sectional study.
Shiyanbola OO; Unni E; Huang YM; Lanier C
BMJ Open; 2018 Nov; 8(11):e022803. PubMed ID: 30478112
[TBL] [Abstract][Full Text] [Related]
32. Adherence to Oral Maintenance Treatment in Adolescents With Inflammatory Bowel Disease.
Spekhorst LM; Hummel TZ; Benninga MA; van Rheenen PF; Kindermann A
J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):264-70. PubMed ID: 26230905
[TBL] [Abstract][Full Text] [Related]
33. Patients' perspectives on antiepileptic medication: relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care.
Chapman SC; Horne R; Chater A; Hukins D; Smithson WH
Epilepsy Behav; 2014 Feb; 31():312-20. PubMed ID: 24290250
[TBL] [Abstract][Full Text] [Related]
34. Behavioral functioning in youth with inflammatory bowel disease: perceived barriers as mediator of medication adherence.
Reed-Knight B; Lewis JD; Blount RL
J Pediatr Psychol; 2013 Apr; 38(3):309-20. PubMed ID: 23248344
[TBL] [Abstract][Full Text] [Related]
35. Impact of Demographic, Clinical and Psychosocial Variables on Drug Adherence and Outcomes in Indian Patients With Inflammatory Bowel Disease: Cost is not the Only Factor!
Banerjee R; Pal P; Adigopula B; Reddy DN
J Clin Gastroenterol; 2021 Nov-Dec 01; 55(10):e92-e99. PubMed ID: 33405436
[TBL] [Abstract][Full Text] [Related]
36. Perceived medication adherence barriers mediating effects between gastrointestinal symptoms and health-related quality of life in pediatric inflammatory bowel disease.
Varni JW; Shulman RJ; Self MM; Saeed SA; Zacur GM; Patel AS; Nurko S; Neigut DA; Franciosi JP; Saps M; Denham JM; Dark CV; Bendo CB; Pohl JF;
Qual Life Res; 2018 Jan; 27(1):195-204. PubMed ID: 28887749
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of a Pharmacist-Led Web-Based Medication Adherence Tool With Patient-Centered Communication: Results of a Clustered Randomized Controlled Trial.
van Lieshout J; Lacroix J; van Halteren A; Teichert M
J Med Internet Res; 2022 Apr; 24(4):e16141. PubMed ID: 35389359
[TBL] [Abstract][Full Text] [Related]
38. Medication beliefs and self-reported adherence among community-dwelling older adults.
Sirey JA; Greenfield A; Weinberger MI; Bruce ML
Clin Ther; 2013 Feb; 35(2):153-60. PubMed ID: 23357585
[TBL] [Abstract][Full Text] [Related]
39. The challenges of assessing patients' medication beliefs: a qualitative study.
Thorneloe RJ; Griffiths CE; Ashcroft DM; Cordingley L
BMC Health Serv Res; 2017 Feb; 17(1):119. PubMed ID: 28173867
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal Barriers to Thiopurine Adherence in Adolescents With Inflammatory Bowel Diseases.
Plevinsky JM; Wojtowicz AA; Miller SA; Greenley RN
J Pediatr Psychol; 2019 Jan; 44(1):52-60. PubMed ID: 30137372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
